Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

医学 吉非替尼 卡铂 危险系数 内科学 肿瘤科 生物标志物 肺癌 表皮生长因子受体 埃罗替尼 基因突变 比例危险模型 酪氨酸激酶抑制剂 无进展生存期 腺癌 紫杉醇 化疗 癌症 突变 置信区间 生物 顺铂 基因 生物化学
作者
Masahiro Fukuoka,Yi‐Long Wu,Sumitra Thongprasert,Patrapim Sunpaweravong,Swan-Swan Leong,Virote Sriuranpong,Tsu-Yi Chao,Kazuhiko Nakagawa,Da-Tong Chu,Nagahiro Saijo,Emma Duffield,Yuri Rukazenkov,Georgina Speake,Haiyi Jiang,Alison Armour,Ka‐Fai To,James Chih‐Hsin Yang,Tony Mok
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:29 (21): 2866-2874 被引量:1522
标识
DOI:10.1200/jco.2010.33.4235
摘要

The results of the Iressa Pan-Asia Study (IPASS), which compared gefitinib and carboplatin/paclitaxel in previously untreated never-smokers and light ex-smokers with advanced pulmonary adenocarcinoma were published previously. This report presents overall survival (OS) and efficacy according to epidermal growth factor receptor (EGFR) biomarker status.In all, 1,217 patients were randomly assigned. Biomarkers analyzed were EGFR mutation (amplification mutation refractory system; 437 patients evaluable), EGFR gene copy number (fluorescent in situ hybridization; 406 patients evaluable), and EGFR protein expression (immunohistochemistry; 365 patients evaluable). OS analysis was performed at 78% maturity. A Cox proportional hazards model was used to assess biomarker status by randomly assigned treatment interactions for progression-free survival (PFS) and OS.OS (954 deaths) was similar for gefitinib and carboplatin/paclitaxel with no significant difference between treatments overall (hazard ratio [HR], 0.90; 95% CI, 0.79 to 1.02; P = .109) or in EGFR mutation-positive (HR, 1.00; 95% CI, 0.76 to 1.33; P = .990) or EGFR mutation-negative (HR, 1.18; 95% CI, 0.86 to 1.63; P = .309; treatment by EGFR mutation interaction P = .480) subgroups. A high proportion (64.3%) of EGFR mutation-positive patients randomly assigned to carboplatin/paclitaxel received subsequent EGFR tyrosine kinase inhibitors. PFS was significantly longer with gefitinib for patients whose tumors had both high EGFR gene copy number and EGFR mutation (HR, 0.48; 95% CI, 0.34 to 0.67) but significantly shorter when high EGFR gene copy number was not accompanied by EGFR mutation (HR, 3.85; 95% CI, 2.09 to 7.09).EGFR mutations are the strongest predictive biomarker for PFS and tumor response to first-line gefitinib versus carboplatin/paclitaxel. The predictive value of EGFR gene copy number was driven by coexisting EGFR mutation (post hoc analysis). Treatment-related differences observed for PFS in the EGFR mutation-positive subgroup were not apparent for OS. OS results were likely confounded by the high proportion of patients crossing over to the alternative treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ajing完成签到,获得积分10
1秒前
丫丫完成签到,获得积分10
1秒前
zhanjl13完成签到,获得积分10
1秒前
CXS完成签到,获得积分10
2秒前
随风完成签到,获得积分10
2秒前
wang完成签到,获得积分20
6秒前
ee完成签到,获得积分10
6秒前
斯文的若颜完成签到,获得积分10
7秒前
楚楚楚完成签到,获得积分10
10秒前
斑马完成签到,获得积分10
11秒前
MRJJJJ完成签到,获得积分10
12秒前
13秒前
老迟到的友菱完成签到,获得积分10
16秒前
zzf完成签到,获得积分10
17秒前
zy0411完成签到,获得积分10
17秒前
太清完成签到 ,获得积分10
17秒前
19秒前
酷炫的大碗完成签到,获得积分10
19秒前
zzf发布了新的文献求助10
20秒前
114555完成签到,获得积分10
22秒前
YOUYOU完成签到,获得积分10
22秒前
谨慎纸飞机完成签到,获得积分10
23秒前
江鹿柒柒完成签到,获得积分10
23秒前
xrkxrk完成签到 ,获得积分0
24秒前
kelaibing完成签到,获得积分10
24秒前
岁末完成签到 ,获得积分10
25秒前
小张完成签到 ,获得积分10
26秒前
26秒前
乐观鸣凤完成签到,获得积分10
27秒前
运敬完成签到 ,获得积分10
27秒前
强公子完成签到,获得积分10
28秒前
29秒前
32秒前
冷酷的闹闹完成签到 ,获得积分10
32秒前
孙孙孙啊完成签到,获得积分10
32秒前
顺心的芝麻完成签到 ,获得积分10
33秒前
hebhm发布了新的文献求助10
33秒前
Donger完成签到 ,获得积分10
33秒前
Sunny完成签到,获得积分10
35秒前
走地坤完成签到,获得积分10
35秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968578
求助须知:如何正确求助?哪些是违规求助? 3513400
关于积分的说明 11167585
捐赠科研通 3248853
什么是DOI,文献DOI怎么找? 1794499
邀请新用户注册赠送积分活动 875131
科研通“疑难数据库(出版商)”最低求助积分说明 804664